GB2223579B - Verocytotoxin receptor assay - Google Patents

Verocytotoxin receptor assay

Info

Publication number
GB2223579B
GB2223579B GB8914498A GB8914498A GB2223579B GB 2223579 B GB2223579 B GB 2223579B GB 8914498 A GB8914498 A GB 8914498A GB 8914498 A GB8914498 A GB 8914498A GB 2223579 B GB2223579 B GB 2223579B
Authority
GB
United Kingdom
Prior art keywords
verocytotoxin
receptor assay
assay
receptor
verocytotoxin receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB8914498A
Other languages
English (en)
Other versions
GB8914498D0 (en
GB2223579A (en
Inventor
Clifford A Lingwood
Mohammed A Karmali
Magdy T Basta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hsc Research Development Corp
Original Assignee
Hsc Research Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hsc Research Development Corp filed Critical Hsc Research Development Corp
Publication of GB8914498D0 publication Critical patent/GB8914498D0/en
Publication of GB2223579A publication Critical patent/GB2223579A/en
Application granted granted Critical
Publication of GB2223579B publication Critical patent/GB2223579B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56916Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/829Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GB8914498A 1988-06-24 1989-06-23 Verocytotoxin receptor assay Expired - Fee Related GB2223579B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/211,289 US5164298A (en) 1988-06-24 1988-06-24 Verocytotoxin receptor assay

Publications (3)

Publication Number Publication Date
GB8914498D0 GB8914498D0 (en) 1989-08-09
GB2223579A GB2223579A (en) 1990-04-11
GB2223579B true GB2223579B (en) 1993-10-20

Family

ID=22786295

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8914498A Expired - Fee Related GB2223579B (en) 1988-06-24 1989-06-23 Verocytotoxin receptor assay

Country Status (3)

Country Link
US (1) US5164298A (fr)
CA (1) CA1329196C (fr)
GB (1) GB2223579B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1018342A3 (fr) * 1991-10-18 2001-04-11 SYNSORB Biotech Inc. Diagnostic et traitement de la dysenterie bactérienne
CA2132953C (fr) * 1992-03-26 2001-01-30 Howard C. Krivan Anticorps monoclonaux monospecifiques des toxines ressemblant a la toxine shiga
US5552294A (en) * 1992-10-20 1996-09-03 Children's Medical Center Corporation Rapid detection of virulence-associated factors
CA2218601A1 (fr) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals, Inc. Traitement contre escherichia coli producteur de verotoxines
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
US5733736A (en) * 1996-12-16 1998-03-31 Springfield College Motility channel pathogen detector and method of use
US20030170248A1 (en) * 1997-12-23 2003-09-11 Jeffrey R. Stinson Humanized monoclonal antibodies that protect against shiga toxin induced disease
FR2778187B1 (fr) * 1998-04-30 2001-06-22 Sanofi Elf Procede de selection de souches bacteriennes
US6858211B1 (en) * 1998-07-20 2005-02-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccines against Escherichia coli O157 infection
JP2009536818A (ja) * 2006-04-20 2009-10-22 ザ ヘンリー エム. ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド 志賀毒性1型タンパク質に基づく方法および組成物
US20090258010A1 (en) * 2006-05-31 2009-10-15 Thallion Pharmaceuticals, Inc. Methods, compositions, and kits for treating shiga toxin associated conditions
CN102292098A (zh) 2009-01-23 2011-12-21 杰克孙M.亨利基金会先进军事医学有限公司 基于志贺毒素2型蛋白的方法和组合物
WO2013012387A1 (fr) * 2011-07-20 2013-01-24 Glycorex Ab Procédé de détection d'une substance à analyser dans un échantillon

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035484A2 (fr) * 1980-03-05 1981-09-09 Gunilla Petterson Källenius Composition à usage thérapeutique ou diagnostique
WO1986004064A1 (fr) * 1984-12-27 1986-07-17 Biocarb Ab Compose et composition utilises pour la therapie et le diagnostic; utilisation de ce compose et de cette composition dans le traitement therapeutique et l'isolement de shigatoxine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
US4411888A (en) * 1981-06-22 1983-10-25 The University Of Rochester Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic Escherichia coli
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4469795A (en) * 1981-08-26 1984-09-04 Edward Ginns Radioassay for monosialoglycosphingolipid (GM1) ganglioside concentration
CH658458A5 (fr) * 1981-12-17 1986-11-14 Lucchini Lab Sa Procede pour l'obtention du lacto-n-norhexaosyl ceramide.
JPS58195265A (ja) * 1982-05-10 1983-11-14 Sony Corp マイクロコンピユ−タ
US4863852A (en) * 1985-07-03 1989-09-05 Virginia Tech Intellectual Properties, Inc. Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035484A2 (fr) * 1980-03-05 1981-09-09 Gunilla Petterson Källenius Composition à usage thérapeutique ou diagnostique
WO1986004064A1 (fr) * 1984-12-27 1986-07-17 Biocarb Ab Compose et composition utilises pour la therapie et le diagnostic; utilisation de ce compose et de cette composition dans le traitement therapeutique et l'isolement de shigatoxine
EP0205547A1 (fr) * 1984-12-27 1986-12-30 BioCarb AB Compose et composition utilises pour la therapie et le diagnostic; utilisation de ce compose et de cette composition dans le traitement therapeutique et l'isolement de shigatoxine

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
J.Biol.Chem. (1987) 262 (35) pp17088-91 Cohen et al. *
J.Cell.Biochem (1986) supp 10(B) p61 Brown et al. *
J.Infect.Disease.(1988) 157 (5) pp1102-1104 Edelman et al. *
Toxicon (1985) 23 (4) p555 Brown et al. *
Zentralbl.Bakteriol.Mikrobiol.Hyg.Abt.1 suppl (1988) 17 Bact.Prot.Tox. pp105-106 Brown et al. *

Also Published As

Publication number Publication date
US5164298A (en) 1992-11-17
GB8914498D0 (en) 1989-08-09
GB2223579A (en) 1990-04-11
CA1329196C (fr) 1994-05-03

Similar Documents

Publication Publication Date Title
GB8705650D0 (en) Assay technique
GB8910958D0 (en) Assay
GB8623494D0 (en) Assay technique
GB2223579B (en) Verocytotoxin receptor assay
GB8822738D0 (en) Theophylline assay
AU103156S (en) Covered bowl
ZA907651B (en) Agglutination assay
GB8628108D0 (en) Riboflavin-linked assay
GB8800292D0 (en) Assay method
EP0355687A3 (en) Self-blocked assay support
GB8820375D0 (en) Assay
GB8621495D0 (en) Assay
GB8822718D0 (en) Assay receptors
GB8809899D0 (en) Assay
GB8803905D0 (en) Assay system
GB8811430D0 (en) Assay device
GB8811429D0 (en) Assay device
GB8811431D0 (en) Assay device
GB8918223D0 (en) Assay
IE881222L (en) Assay for anti-pre-s antibodies
PL276054A1 (en) Batcher
IE881223L (en) Assay for anti-pre-s antibody
GB8719631D0 (en) Assay
GB8707667D0 (en) Assay
GB8714213D0 (en) Assay

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20060623